Phentolamine hydrochloride
SIGMA/P7547 - ≥98% (TLC), powder
Synonym: 2-
CAS Number: 73-05-2
Empirical Formula (Hill Notation): C17H19N3O · HCl
Molecular Weight: 317.81
EC Number: 200-793-5
MDL Number: MFCD00079268
Linear Formula: C17H19N3O · HCl
Product Type: Chemical
| assay | ≥98% (TLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C17H19N3O.ClH/c1-13-5- |
| InChI key | TUEJFGFQYKDAPM-UHFFFAOYSA |
| originator | Novartis |
| Quality Level | 200 ![]() |
| SMILES string | Cl[H].Cc1ccc(cc1)N(CC2=NC |
| solubility | ethanol: 14 mg/mL |
| H2O: 20 mg/mL | |
| H2O: unstable (prepare immediately prior to use) |
| Biochem/physiol Actions: | α-adrenoceptor antagonist; peripheral vasodilator. |
| Features and Benefits: | This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 100, 500 mg in glass bottle |
| Preparation Note: | Protect From Light. |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P264 - P270 - P301 + P312 - P501 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 22-24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (TLC) |
| UNSPSC | 12352116 |


